Alexandria Real Estate Equities, Inc. (ARE)

Alexandria Real Estate Equities, Inc. (ARE) has experienced a significant decline in its stock price, decreasing by 39.46% from July 17, 2024, to July 16, 2025, and is trading around 70% below its all-time high from early 2022. Despite these challenges, the company secured a 16-year lease for 466,598 rentable square feet at its Campus Point Megacampus in San Diego, marking the largest lease in Alexandria's history. Analysts anticipate ARE's quarterly earnings release on July 21, 2025, with expected earnings per share (EPS) of $2.29 and revenue of approximately $748 million. The company's occupancy rate for operating properties was 91.7% as of March 31, 2025, and 91.7% in the first quarter of 2025, which was down from 94.6% in the same period last year. However, Alexandria had raised its annual funds from operations (FFO) forecast as of September 30, 2024, due to an occupancy rate of 94.7% for its operating properties, up from 93.7% a year prior, driven by increased healthcare research funding and interest rate cuts.

While a 2019 annual report indicated "no seasonality in business" for their tenants, the demand for ARE's products and services is primarily driven by the long-term growth potential of the life science industry and increased healthcare research funding. The company's focus on developing and operating properties for life science, agtech, and technology tenants suggests a consistent need for their specialized spaces. Federal interest rate cuts can also promote more research activities, further sustaining demand in the sector.

Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust (REIT) specializing in office and laboratory spaces for the life science and technology industries in North America. Founded in 1994 and headquartered in Pasadena, California, Alexandria pioneered the life science real estate niche. The company's major products include rentable properties, cluster developments, and incubators tailored for the life science industry. They focus on developing, owning, and operating collaborative "Megacampus™" ecosystems and offer strategic capital to select companies through Alexandria Venture Investments. As of March 31, 2025, Alexandria's asset base in North America included 39.6 million rentable square feet (RSF) of operating properties and 4.0 million RSF of properties under construction.

Alexandria Real Estate Equities has a significant market presence in key life science innovation clusters across North America, including Greater Boston, New York City, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle (North Carolina), Texas, and Canada.

Alexandria Real Estate Equities, Inc. has maintained a strong brand reputation, being named one of Newsweek's Most Trustworthy Companies in America for the second consecutive year in April 2024. Alexandria also won the 2025 International TOBY Award for 8 Davis Drive and has earned eight Nareit Investor CARE Awards. In 2023, Alexandria received its sixth consecutive GRESB "A" disclosure score with a perfect score of 100 and a #1 ranking for transparency in its sustainability practices and reporting.

The ownership of Alexandria Real Estate Equities, Inc. is primarily dominated by institutional investors, holding approximately 95.96% of the shares as of March 31, 2025. Major institutional shareholders include Vanguard Group Inc., BlackRock, Inc., State Street Corp, JPMorgan Chase & Co, APG Asset Management US Inc., Canada Pension Plan Investment Board, Geode Capital Management, Llc, and Norges Bank (The Central Bank of Norway). Individual investors and public companies hold approximately 27.21% of the stock, while insiders held 1.67% as of March 2025.